@NeurIPSConference 2025 is just around the corner, and the @IsomorphicLabs team is getting ready for a busy week in San Diego.We’re looking forward to meeting ML Engineers, ML Research Engineers, and ML Research Scientists at all levels to join our teams in London and Lausanne. Share your details through the link in the comments. We can’t wait to meet you!Link: https://t.co/HIozXPWYEU ...

Read the blog here!https://t.co/MPnzlbnL6a ...

Curious about what it’s like to work at Isomorphic Labs’ Swiss location? In our latest blog post we're taking you inside IsoLabs' Lausanne office to learn about its history and meet some of the Isos based there.Since opening in 2023, Lausanne has grown into a close-knit hub where data engineers, ML researchers, computational biologists and software engineers work together to solve complex problems every day.Head to the comments to read the blog! ...

@ASAP_Global https://t.co/P4ZcNkyDCj ...

Partnerships and strategic collaborations are key to our mission to one day solve all disease. Hear more about how alliances are critical accelerators of AI innovation by joining our Chief Business and Legal Officer, Sarah Korman, on 19 November at the @ASAP_Global BioPharma Conference in Boston.Head to the comments to register. ...

Sarah Korman joined @EmTechMIT in Boston last week. In her keynote, Sarah shared how @IsomorphicLabs is applying frontier AI to unlock faster breakthroughs, and how these advances could open up new possibilities for drug design.Thank you to the team at MIT for hosting! https://t.co/53b80JPiMm ...

Event Details - Isomorphic Labs' Chief Medical Officer, Ben Wolf, will participate in a fireside chat at the Fast Company World Changing Ideas Summit [1] - The session will be held on Wednesday, November 19, from 11:45 AM to 12:15 PM ET [1] - The discussion will focus on how Isomorphic Labs is transforming drug discovery and accelerating new treatments [1] Focus Area - Isomorphic Labs is aiming to accelerate new treatments for some of the world's most challenging diseases [1]

Hear more about our work unlocking new possibilities for drug discovery by joining our Chief Scientific Officer, @MilesCcc, in Boston at the AI-Driven Drug Discovery Summit 2025 at 12:45 EST on 19 November.In his presentation, Miles will explore AI-driven protein structure prediction, sharing insights from our work at Isomorphic Labs and what it means for the discovery of new medicines.Find out more here: https://t.co/SYwbF4b8p1 ...

Based on the provided content, it's difficult to provide a detailed analysis without more context, but here's a general interpretation: General Information - The content is a tweet from a user named @_rebecca_paul [1] - The tweet includes a URL: https://t.co/rGa9lmil1s [1] Without knowing the content of the URL, it's impossible to provide more specific insights related to industry trends, investment opportunities, or financial performance

Company Activities - The company's Head of Medicinal Drug Design, Rebecca Paul, will present on AI drug design at the SCI New Approaches in Medicinal Chemistry symposium [1] - The presentation is scheduled for November 12 at 16:00 GMT in London [1] Event Details - The event is the SCI New Approaches in Medicinal Chemistry symposium [1] - The symposium will be held in London [1]